We are live on ! Find out more
JHP

James Hambro & Partners Portfolio holdings

AUM $2.76B
1-Year Est. Return 19.67%
This Fund
S&P 500
This Quarter Est. Return
+11.49%
1 Year Est. Return
+19.67%
3 Year Est. Return
+79.16%
5 Year Est. Return
+89.36%
10 Year Est. Return
–
AUM
$2.53B
AUM Growth
+$131M
Cap. Flow
-$86.1M
Cap. Flow %
-3.41%
Top 10 Hldgs %
63.35%
Holding
54
New
–
Increased
17
Reduced
22
Closed
4

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$9.58M
2
AMZN icon
Amazon
AMZN
+$6.61M
3
TXN icon
Texas Instruments
TXN
+$5.18M
4
ENTG icon
Entegris
ENTG
+$5.05M
5
ISRG icon
Intuitive Surgical
ISRG
+$5.01M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$129M
2
APH icon
Amphenol
APH
+$3.8M
3
PGR icon
Progressive
PGR
+$3M
4
IRM icon
Iron Mountain
IRM
+$2.27M
5
V icon
Visa
V
+$1.37M

Sector Composition

Rank Sector Weight
1 Financials 30.93%
2 Technology 27.89%
3 Healthcare 11.5%
4 Consumer Discretionary 9.63%
5 Industrials 8.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACN icon
51
Accenture
ACN
$102B
– –
-697
Closed -$218K
NVO
52
Novo Nordisk
NVO
$208B
– –
-16,090
Closed -$1.12M
UNH icon
53
UnitedHealth
UNH
$376B
– –
-245,642
Closed -$129M
WTW icon
54
Willis Towers Watson
WTW
$31.2B
– –
-1,678
Closed -$567K
1 2
3

Similar funds

NSLI
Nan Shan Life Insurance Taipei City, Taiwan $2.76B AUM 6.75% 1-Year Est. Return
JFGIW
Johnson Financial Group Inc (Wisconsin) Racine, Wisconsin $2.76B AUM 19.4% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return
SAM
Smartleaf Asset Management Boston, Massachusetts $2.77B AUM 22% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return
SFFS
Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return
CC
Cartenna Capital Stamford, Connecticut $2.74B AUM 44.46% 1-Year Est. Return
MC
Maplelane Capital New York $2.79B AUM 52.02% 1-Year Est. Return

James Hambro & Partners's Q2 2025 Portfolio in Review

As of Q2 2025, James Hambro & Partners held 54 positions worth $2.53B, up 5.5% from $2.4B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

James Hambro & Partners withdrew a net $86.1M in Q2 2025, closing 4 positions and reducing 22 holdings. Its most notable exit was UnitedHealth, an estimated $129M position sold in full.

By sector, the portfolio is most concentrated in Financials at 31% of assets, up from 31% a quarter earlier, followed by Technology and Healthcare.

Against the trend, James Hambro & Partners added an estimated $9.58M to Thermo Fisher Scientific.

  • James Hambro & Partners added most to Thermo Fisher Scientific in Q2 2025, an estimated $9.58M increase.
  • James Hambro & Partners's biggest Q2 2025 reduction was Amphenol, cutting an estimated $3.8M.
  • James Hambro & Partners fully exited UnitedHealth in Q2 2025, selling an estimated $129M.
  • James Hambro & Partners's ten largest holdings make up 63% of its $2.53B portfolio in Q2 2025.
  • James Hambro & Partners opened 0 new positions and closed 4 in Q2 2025.
  • James Hambro & Partners's portfolio value rose 5.5% quarter-over-quarter to $2.53B.

Based on James Hambro & Partners's 13F filing for Q2 2025, filed 17 Jul 2025.